| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.007 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.007 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | 0.16 | 0.007 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.1 | 0.007 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.085 | 0.007 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | 0.088 | 0.008 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | -0.083 | 0.008 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | 0.095 | 0.009 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | 0.088 | 0.009 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | -0.084 | 0.01 |